Showing results (141-150 of 179) with videos related to

Sort By:
Pageof 18
Scientific Reports|December 6, 2023
Development of a nomogram to predict survival in advanced biliary tract cancerHiroshi Imaoka, Masafumi Ikeda, Shogo Nomura, et al.
Pancreas|April 24, 2018
Nationwide Multicenter Observational Study of FOLFIRINOX Chemotherapy in 399 Patients With Unresectable or Recurrent Pancreatic Cancer in JapanAkiko Todaka, Nobumasa Mizuno, Masato Ozaka, et al.
International Journal of Clinical Oncology|April 12, 2024
English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical OncologySeiichi Hirota, Ukihide Tateishi, Yuji Nakamoto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2025
Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin or S-1, Irinotecan, and Oxaliplatin Versus Nab-Paclitaxel + Gemcitabine in Metastatic or Recurrent Pancreatic Cancer (GENERATE, JCOG1611): A Randomized, Open-Label, Phase II/III TrialAkihiro Ohba, Masato Ozaka, Junki Mizusawa, et al.
Pancreas|December 28, 2020
Multicenter Retrospective Analysis of Chemotherapy for Advanced Pancreatic Acinar Cell Carcinoma: Potential Efficacy of Platinum- and Irinotecan-Containing RegimensHideaki Takahashi, Masafumi Ikeda, Satoshi Shiba, et al.
European Journal of Cancer (Oxford, England : 1990)|April 19, 2025
Phase 1/2 study of liposomal irinotecan plus S-1 for metastatic pancreatic cancer refractory to gemcitabine-based treatmentHiroshi Imaoka, Masafumi Ikeda, Masato Ozaka, et al.
International Journal of Clinical Oncology|July 24, 2025
Comparison of clinical features by primary site in patients with biliary tract cancer who received gemcitabine-based chemotherapy: an exploratory analysis of JCOG1113Yuko Suzuki, Masafumi Ikeda, Junki Mizusawa, et al.
Japanese Journal of Clinical Oncology|March 7, 2025
Impact of clinically diagnosed liver cirrhosis in patients with intrahepatic cholangiocarcinoma treated with systemic chemotherapy: a subgroup analysis of JCOG1113Mao Okada, Eiichiro Suzuki, Chigusa Morizane, et al.
JAMA Oncology|August 18, 2022
Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive System: The TOPIC-NEC Phase 3 Randomized Clinical TrialChigusa Morizane, Nozomu Machida, Yoshitaka Honma, et al.
Pancreas|February 4, 2020
A Multicenter Retrospective Study of Gemcitabine Plus Nab-Paclitaxel for Elderly Patients With Advanced Pancreatic CancerSatoshi Kobayashi, Makoto Ueno, Masafumi Ikeda, et al.
Pageof 18